CNS Co (4076) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
22 Jul, 2026Executive summary
Revenue for the nine months ended February 2026 rose 10.2% year-over-year to ¥5,717 million, with operating profit up 29.8% and net profit attributable to shareholders up 38.6%.
Growth was driven by robust IT demand, especially in DX and AI, despite ongoing IT talent shortages.
Strategic partnerships in DX/AI and ERP, as well as a headquarters relocation, supported business expansion and operational efficiency.
Financial highlights
Operating profit reached ¥546 million, up 29.8% year-over-year; ordinary profit was ¥570 million, up 28.8%.
Net profit attributable to shareholders was ¥415 million, up 38.6% year-over-year.
EPS for the period was ¥142.92, compared to ¥103.09 in the prior year.
Total assets increased to ¥5,428 million, and net assets to ¥4,156 million.
Outlook and guidance
Full-year revenue forecast revised upward to ¥8,253 million (+17.8% YoY), with operating profit of ¥710 million (+27.9%) and net profit of ¥532 million (+24.5%).
Dividend forecast raised to ¥75 per share, reflecting improved earnings.
Management cautions that actual results may differ due to various uncertainties.
Latest events from CNS Co
- Double-digit revenue growth driven by DX and consulting, with profit growth to continue.4076
Q4 202422 Jul 2026 - Profit dropped sharply in Q1 FY2025 despite stable revenue, as labor costs surged.4076
Q1 202522 Jul 2026 - Revenue up 2.0% YoY, but profit down on higher costs; full-year outlook maintained.4076
Q2 202522 Jul 2026 - Revenue up 4.1% year-over-year, but profit margins declined on higher personnel costs.4076
Q3 202522 Jul 2026 - Revenue up 5.2% year-over-year, but profit margins declined amid higher costs and investments.4076
Q4 202522 Jul 2026 - Q1 FY2026 delivered double-digit profit growth, with all segments contributing to higher earnings.4076
Q1 202622 Jul 2026 - Revenue and profits surged on robust DX/AI demand, prompting an upward revision to full-year guidance.4076
Q2 202622 Jul 2026 - Strong revenue and profit growth driven by DX/AI, with double-digit gains and robust FY2027 outlook.4076
Q4 202622 Jul 2026